sales@angenesci.com
Login | Register
logo
Structures Search
Home Aminos N-[(4-amino-2-methylpyrimidin-5-yl)methyl]-N-[(2Z)-5-hydroxy-3-(propyldisulfanyl)pent-2-en-2-yl]formamide

N-[(4-amino-2-methylpyrimidin-5-yl)methyl]-N-[(2Z)-5-hydroxy-3-(propyldisulfanyl)pent-2-en-2-yl]formamide

CAS No.:
59-58-5
Catalog Number:
AG00IAHE
Molecular Formula:
C15H24N4O2S2
Molecular Weight:
356.5067
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
1g
96%
In Stock USA
United States
$32
- +
5g
96%
In Stock USA
United States
$119
- +
25g
96%
In Stock USA
United States
$369
- +
100g
96%
In Stock USA
United States
$863
- +
Product Description
Catalog Number:
AG00IAHE
Chemical Name:
N-[(4-amino-2-methylpyrimidin-5-yl)methyl]-N-[(2Z)-5-hydroxy-3-(propyldisulfanyl)pent-2-en-2-yl]formamide
CAS Number:
59-58-5
Molecular Formula:
C15H24N4O2S2
Molecular Weight:
356.5067
MDL Number:
MFCD00023265
IUPAC Name:
N-[(4-amino-2-methylpyrimidin-5-yl)methyl]-N-[(E)-5-hydroxy-3-(propyldisulfanyl)pent-2-en-2-yl]formamide
InChI:
InChI=1S/C15H24N4O2S2/c1-4-7-22-23-14(5-6-20)11(2)19(10-21)9-13-8-17-12(3)18-15(13)16/h8,10,20H,4-7,9H2,1-3H3,(H2,16,17,18)/b14-11+
InChI Key:
UDCIYVVYDCXLSX-SDNWHVSQSA-N
SMILES:
OCC/C(=C(\N(Cc1cnc(nc1N)C)C=O)/C)/SSCCC
EC Number:
200-436-3
UNII:
UI32MM3XE3
Properties
Complexity:
396  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
1  
Exact Mass:
356.134g/mol
Formal Charge:
0
Heavy Atom Count:
23  
Hydrogen Bond Acceptor Count:
7  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0
Molecular Weight:
356.503g/mol
Monoisotopic Mass:
356.134g/mol
Rotatable Bond Count:
9  
Topological Polar Surface Area:
143A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
1.1  
Literature
Title Journal
Why are most phospholipidosis inducers also hERG blockers? Archives of toxicology 20171201
Cortical hemodynamic responses to intravenous thiamine propyldisulphide administration detected by multichannel near infrared spectroscopy (NIRS) system. Brain topography 20110601
[Effect of Alinamin F and Kakkontou on mucoid Pseudomonas aeruginosa chronic lower respiratory tract infection]. Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society 20090301
Disulfide-mediated apoptosis of human T-lymphotrophc virus type-I (HTLV-I)-infected cells in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis. Antiviral therapy 20090101
Human brain activation in response to olfactory stimulation by intravenous administration of odorants. Neuroscience letters 20070809
Smell intensity monitoring using metal oxide semiconductor odor sensors during intravenous olfaction test. Chemical senses 20060101
Neuromagnetic changes of brain rhythm evoked by intravenous olfactory stimulation in humans. Brain topography 20060101
[Prognosis in olfaction disorders]. Nihon Jibiinkoka Gakkai kaiho 20041001
Potential oscillation elicited by i.v. olfaction and its applicability as an objective clinical olfaction test. Acta oto-laryngologica. Supplementum 20040801
Hemodynamic response of the frontal cortex elicited by intravenous thiamine propyldisulphide administration. Chemical senses 20040301
Potential changes with gamma-band oscillation at the frontal scalp elicited by intravenous olfactory stimulation in humans. Chemical senses 20021001
Electroencephalographic changes during intravenous olfactory stimulation in humans. Clinical EEG (electroencephalography) 20021001
Properties